Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Orphanet Journal of Rare Diseases|August 20, 2025
Development of a conceptual model of early systemic sclerosis (scleroderma)William R Lenderking, Mary Kathleen Ladd, Nicola Barnes, et al.
Health and Quality of Life Outcomes|September 20, 2024
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancerSiobhan Bourke, Bryan Bennett, Yemi Oluboyede, et al.
Haematologica|August 30, 2023
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT studyLeo I Gordon, Fei Fei Liu, Julia Braverman, et al.
Allergy and Asthma Proceedings|May 17, 2025
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimabPetra Staubach, Timothy J Craig, Tomoo Fukuda, et al.
Allergy and Asthma Proceedings|May 17, 2025
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedemaMar Guilarte, William R Lumry, Markus Magerl, et al.
Blood Advances|December 21, 2021
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myelomaMichel Delforge, Nina Shah, Jesús San F Miguel, et al.
Leukemia Research|April 23, 2023
Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: Longitudinal findings from the phase 2 KarMMa trialMichel Delforge, Paula Rodríguez Otero, Nina Shah, et al.
European Urology Oncology|March 15, 2022
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 TrialJohannes Alfred Witjes, Matthew D Galsky, Jürgen E Gschwend, et al.
Annals of Surgical Oncology|April 4, 2021
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic AdenocarcinomaMichele Reni, Julia Braverman, Andrew Hendifar, et al.
Leukemia Research|August 5, 2022
Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trialNina Shah, Michel Delforge, Jesus San-Miguel, et al.
Pageof 4